Integrity Alliance’s GSK GSK Stock Holding History

Integrity Alliance’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$221K	Buy	+4,580	New	+$234K	0.01%	852

Other funds holding GSK

Mondrian Investment Partners London, United Kingdom $5.39B AUM 14.53% 1-Year Est. Return

Miller Howard Investments Kingston, New York $3.72B AUM 18.2% 1-Year Est. Return

BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return

Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

ABC Arbitrage Paris, France $1.02B AUM 30.46% 1-Year Est. Return

Foster Victor Wealth Advisors Greenville, South Carolina $2.02B AUM 20.94% 1-Year Est. Return

Sound Income Strategies Ft Lauderdale, Florida $2.24B AUM 8.38% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return

Stockman Wealth Management Billings, Montana $960M AUM 19.88% 1-Year Est. Return

Integrity Alliance's GSK Position: Q3 2026 in Review

Integrity Alliance opened a new position in GSK (GSK) in Q3 2026: 4,580 shares worth $221K. The stake represents 0.01% of the portfolio and ranks #852 among its holdings.

382 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

Integrity Alliance held 4,580 shares of GSK worth $221K as of Q3 2026.
GSK was a new Integrity Alliance position in Q3 2026.
GSK made up 0.01% of Integrity Alliance's portfolio in Q3 2026, its #852 holding.
382 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Integrity Alliance's 13F filing for Q3 2026, filed 29 Oct 2026.